Clinical trial
A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID…
NCT00004845 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00004845 |
|---|---|
| Title | A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study) |
| Official title | A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Alzheimer's Disease Cooperative Study (ADCS) |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Rofecoxib, Naproxen |
| Primary completion | Dec 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Feb 29, 2000 |
| Last update posted | Dec 11, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: